FIELD: medicine, pharmaceutics.
SUBSTANCE: claimed is a pharmaceutical, ear, sterile, preservative-free composition in the form of a transparent aqueous solution, containing 0.01-0.025 % of fluocinilone acetonide optionally in a combination with 0.1-0.8% of ciprofloxacin or its pharmaceutically acceptable salt, a non-ionic surface-active substance, a tonicity-regulating agent and a viscosity-increasing agent.
EFFECT: composition is useful for the prevention and/or treatment of ear inflammation, optionally accompanied with a bacterial infection, and for the introduction of a single dose from a package.
15 cl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| FINAFLOXACIN-INCLUDING COMPOSITIONS, AND METHODS OF TREATING OPHTHALMOLOGICAL, AURAL AND NASAL INFECTIONS | 2010 |
|
RU2570731C2 |
| DISPERSIBLE PREPARATION OF ANTIINFLAMMATION AGENT | 2004 |
|
RU2319508C2 |
| METHOD AND PHARMACEUTICAL COMPOSITION FOR ANTIPHLOGISTIC AGENT DELIVERY | 2004 |
|
RU2325189C2 |
| CLOBETAZOLE COMPOSITION IN THE FORM OF OIL-IN-WATER NANO-EMULSION | 2018 |
|
RU2759901C2 |
| METHOD FOR TREATING MIDDLE EAR INFECTION CASES | 2002 |
|
RU2295346C2 |
| FINAFLOXACIN SUSPENSION COMPOSITIONS | 2013 |
|
RU2693476C2 |
| COMPOSITIONS CONTAINING ANTIBIOTIC AND CORTICOSTEROID | 2009 |
|
RU2496501C2 |
| COMPOSITION FOR SKIN CARE, INTENDED FOR LOCAL APPLICATION | 2003 |
|
RU2350313C2 |
| ANTIINFLAMMATORY AND ANTIMYCOTIC PHARMACEUTICAL COMPOSITION, A METHOD OF ITS PREPARING, USE OF KETOCONAZOLE AS AN AGENT ENHANCING ANTIINFLAMMATORY EFFECT OF GLUCOCORTICOSTEROID- -ACETONIDE, A SET CONTAINING COMPONENTS SAID | 1994 |
|
RU2126256C1 |
| PHARMACEUTICAL COMPOSITION | 2005 |
|
RU2394573C2 |
